Fox Run Management L.L.C. Takes $428,000 Position in Alignment Healthcare, Inc. $ALHC

Fox Run Management L.L.C. bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 30,585 shares of the company’s stock, valued at approximately $428,000.

Several other large investors have also recently added to or reduced their stakes in the stock. MCF Advisors LLC raised its position in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare in the first quarter valued at about $42,000. Signaturefd LLC raised its holdings in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after buying an additional 2,215 shares during the period. Regal Partners Ltd purchased a new stake in shares of Alignment Healthcare during the 1st quarter valued at about $194,000. Finally, CWM LLC lifted its position in Alignment Healthcare by 137.6% during the 1st quarter. CWM LLC now owns 10,553 shares of the company’s stock worth $196,000 after acquiring an additional 6,112 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ALHC has been the topic of a number of analyst reports. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective on the stock in a research note on Monday, August 25th. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. The Goldman Sachs Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. Barclays raised their target price on Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, October 31st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $19.85.

Alignment Healthcare Trading Up 0.7%

ALHC opened at $16.60 on Thursday. Alignment Healthcare, Inc. has a 12-month low of $10.18 and a 12-month high of $21.06. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market capitalization of $3.32 billion, a PE ratio of -138.33 and a beta of 1.17. The firm’s fifty day moving average price is $16.96 and its 200 day moving average price is $15.42.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company’s revenue was up 43.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.14) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the transaction, the president owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. This trade represents a 10.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John E. Kao sold 180,000 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $16.32, for a total value of $2,937,600.00. Following the sale, the chief executive officer directly owned 2,526,726 shares in the company, valued at approximately $41,236,168.32. This represents a 6.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 7,593,948 shares of company stock valued at $122,396,905 over the last 90 days. Corporate insiders own 7.00% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.